Aznar-Salatti J, Bastida E, Buchanan M R, Castillo R, Ordinas A, Escolar G
Servicio Hemoterapia i Hemostasia, Hospital Clinic, Facultad de Medicina, Universidad de Barcelona, Spain.
Histochemistry. 1990;93(5):507-11. doi: 10.1007/BF00266409.
Von Willebrand factor (vWF), fibronectin (FN) and 13-hydroxy-octadecadienoic acid (13-HODE) are known to influence the regulation of the adhesive properties of vascular surfaces. In the present study vWF, FN and 13-HODE were comparatively localized in endothelial cells (EC) and in the extracellular matrix (ECM) produced by EC. An indirect immunofluorescent technique was applied to coverslips containing human EC cultures previously fixed and permeabilized following different procedures: A. Alcohol/acetone; B. Paraformaldehyde alone and C. Paraformaldehyde followed by Triton X-100. vWF was observed inside EC (A), on the ECM produced by EC (B) or in EC and ECM (C) depending on the fixation procedures used. FN was mainly localized in the ECM despite the fixation procedures employed. FN was only seen in relation to cell bodies after strong permeabilization (A). Under our experimental conditions 13-HODE was never found in ECM. This latter antigen was observed randomly dispersed in those preparations fixed with alcohol/acetone, indicating that it is probably extracted by this fixative. 13-HODE was detected in granular shaped structures in EC after permeabilization with detergent (C). These results suggest that the cellular localization of vWF and FN is compatible with an adhesive role related to the abluminal side of ECs. 13-HODE was readily observed after mild permeabilization. This finding would be morphologically consistent with its contribution to the regulation of the vessel wall thromboresistance.
已知血管性血友病因子(vWF)、纤连蛋白(FN)和13-羟基十八碳二烯酸(13-HODE)会影响血管表面黏附特性的调节。在本研究中,对vWF、FN和13-HODE在内皮细胞(EC)以及EC产生的细胞外基质(ECM)中的定位进行了比较。采用间接免疫荧光技术,将其应用于预先按照不同程序固定并通透处理的含有人EC培养物的盖玻片上:A.乙醇/丙酮;B.单独使用多聚甲醛;C.多聚甲醛后用Triton X-100处理。根据所使用的固定程序,在EC内部(A)、EC产生的ECM上(B)或EC和ECM中(C)观察到vWF。尽管采用了不同的固定程序,FN主要定位于ECM中。只有在经过强通透处理(A)后,才能在与细胞体相关的位置看到FN。在我们的实验条件下,从未在ECM中发现13-HODE。在用乙醇/丙酮固定的制剂中,这种抗原呈随机分散分布,这表明它可能被这种固定剂提取出来了。在用去污剂通透处理(C)后,在EC中的颗粒状结构中检测到13-HODE。这些结果表明,vWF和FN的细胞定位与其在内皮细胞腔外侧的黏附作用相符。在轻度通透处理后很容易观察到13-HODE。这一发现从形态学上与其对血管壁抗血栓形成调节的作用相一致。